Abstract
Background
Reduction mammaplasty is a common operation performed for healthy women. The estimated incidence of breast cancer diagnosed at the time of reduction mammaplasty varies from 0.06 to 4.5%, and information on the care of these patients is limited. This study aimed to determine the incidence of breast cancer identified incidentally during reduction mammaplasty and to characterize preoperative imaging.
Methods
Women 18 years of age or older who underwent reduction mammaplasty from 2013 to 2015 were identified from the Truven Health MarketScan® Research Databases. Patients with prior breast cancer were excluded. Descriptive statistics were calculated for patient characteristics, incidental breast cancer, preoperative breast imaging, and postoperative treatment.
Results
Reduction mammaplasty was performed for 18,969 women with a mean age of 42.5 years. Of these patients, 186 (0.98%) were incidentally found to have breast cancer, with 134 (0.71%) having invasive breast cancer and 52 (0.27%) having carcinoma in situ. The patients with incidentally found cancer were older than the patients without cancer (50.8 vs. 42.5 years; p < 0.001). Overall, 58.2% of the patients had undergone mammography before reduction mammoplasty. The rates were higher (> 80%) for the patients older than 40 years. Preoperative mammography was performed for 76.3% of those with a diagnosis of breast cancer at time of reduction mammoplasty.
Conclusions
Breast cancer diagnosed incidentally at the time of reduction mammaplasty is uncommon and often radiographically occult. The majority of women older than 50 years appropriately received preoperative mammography. These data can be used to manage patient expectations about the potential for the incidental diagnosis of breast cancer at reduction mammaplasty, even with a negative preoperative mammography.
Similar content being viewed by others
References
American Society of Plastic Surgeons. Plastic surgery statistics report. 2017. Retrieved 2 Oct 2018 at https://www.plasticsurgery.org/documents/News/Statistics/2017/plastic-surgery-statistics-full-report-2017.pdf.
Acevedo F, Armengol VD, Deng Z, et al. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2018;173: 201–7.
Bruhlmann Y, Tschopp H. Breast reduction improves symptoms of macromastia and has a long-lasting effect. Ann Plast Surg. 1998;41:240–5.
Ducic I, Iorio ML, Al-Attar A. Chronic headaches/migraines: extending indications for breast reduction. Plast Reconstr Surg. 2010;125:44–9.
Perez-Panzano E, Gascon-Catalan A, Sousa-Dominguez R, Carrera-Lasfuentes P, Garcia-Campayo J, Guemes-Sanchez A. Reduction mammaplasty improves levels of anxiety, depression, and body image satisfaction in patients with symptomatic macromastia in the short and long term. J Psychosom Obstet Gynaecol. 2017;38:268–75.
Blomqvist L, Eriksson A, Brandberg Y. Reduction mammaplasty provides long-term improvement in health status and quality of life. Plast Reconstr Surg. 2000;106:991–7.
Uson Junior PLS, Callegaro Filho D, Bugano DDG, et al. Incidental findings in reduction mammoplasty specimens in patients with no prior history of breast cancer. An analysis of 783 specimens. Pathol Oncol Res. 2018;24:95–9.
Tadler M, Vlastos G, Pelte MF, et al. Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients. Br J Cancer. 2014;110:788–91.
Waldner M, Klein HJ, Kunzi W, Guggenheim M, Plock JA, Giovanoli P. Occurrence of occult malignancies in reduction mammoplasties. Front Surg. 2018;5:17.
Merkkola-von Schantz P, Jahkola T, Carpelan A, Krogerus L, Hukkinen K, Kauhanen S. Adverse histopathology and imaging findings in reduction mammaplasty day-surgery patients. Scand J Surg. 2014;103:209–14.
Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009;124:1386–92.
Boice JD Jr, Friis S, McLaughlin JK, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control. 1997;8:253–8.
Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286–9.
Desouki MM, Li Z, Hameed O, Fadare O, Zhao C. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health centers. Hum Pathol. 2013;44:1877–81.
Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg. 1999;103:1682–6.
Greco R, Noone B. Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg. 2017;139:230e–9e.
Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599–614.
The American Society of Breast Surgeons. Consensus Statement on Screening Mammography. 2015. Retrieved 25 March 2019 at https://www.breastsurgeons.org/about/statements/PDF_Statements/Screening_Mammography.pdf.
Keleher AJ, Langstein HN, Ames FC, et al. Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J. 2003;9:120–5.
Butler CE, Hunt KK, Singletary SE. Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003;50:193–7.
Brown FE, Sargent SK, Cohen SR, Morain WD. Mammographic changes following reduction mammaplasty. Plast Reconstr Surg. 1987;80:691–8.
Danikas D, Theodorou SJV, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesth Plast Surg. 2001;25:283–5.
Slezak S, Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy. Plast Reconstr Surg. 2011;127:525–30.
Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006;72:397–400.
Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124:1033–9.
Young ZT, Close M, Herrera FA. National surgical quality improvement program analysis of 9110 reduction mammaplasty patients: identifying risk factors associated with complications in patients older than 60 years. Ann Plast Surg. 2019;82(6S Suppl 5):S446–9.
Winter R, Haug I, Lebo P, et al. Standardizing the complication rate after breast reduction using the Clavien-Dindo classification. Surgery. 2017;161:1430–5.
Acknowledgment
Drs. Walle, Stankowski-Drengler, and Livingston-Rosanoff are supported by NIH training grant T32 CA090217. Dr. Livingston-Rosanoff also is supported by the American College of Surgeons Resident Research Scholarship. Support for this project was provided by the Wisconsin Surgical Outcomes Research Program in the University of Wisconsin-Madison (UW-Madison) Department of Surgery, with additional support from the UW-Madison Institute for Clinical and Translational Research Community-Academic Partnership (ICTR-CAP) via NIH CTSA award UL1TR000427 and UW-Madison School of Medicine and Public Health’s Wisconsin Partnership Program WPP-ICTR grant #3086. MarketScan is a registered trademark of Truven Health Analytics Inc.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
See Table 4.
Rights and permissions
About this article
Cite this article
Vande Walle, K., Yang, DY.Y., Stankowski-Drengler, T.J. et al. Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women. Ann Surg Oncol 26, 4310–4316 (2019). https://doi.org/10.1245/s10434-019-07726-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07726-9